Eli Lilly's $300 Million DeSci Investment
Pharmaceutical giant Eli Lilly ($LLY), with a market valuation of $1 trillion, has invested $300 million into the $BIO Protocol. This significant capital injection is three times $BIO's prior market capitalization of $100 million, marking Eli Lilly's entry into the decentralized science (DeSci) sector. The $BIO Protocol's ecosystem includes projects such as $peptai_, which utilizes AI agents for peptide drug discovery.
$BIO Token Price Performance and Market Reaction
Over three weeks, its value surged by 300%. On May 2nd, the token registered an initial 54.42% gain, followed by an additional 55% increase later the same day. Within a single week, $BIO's value climbed by 118%. Intraday movements on May 2nd included a 16.1% increase from $0.04522. Further increases were recorded on Binance Spot (USDT), with a 3.25% rise to $0.0572, and on Coinbase Spot (USD), with a 3.19% rise to $0.05405. The current price of $BIO is $0.053852, reflecting a 6.5% gain over 24 hours and an 84.1% gain over seven days. Ruma's sentiment analysis for $BIO registered an overall bullish score of 0.88, reflecting the positive market reaction.
Team Token Transfers and Community Response
Following the token's price appreciation, multi-signature wallets linked to the $BIO team transferred 80 million $BIO tokens, valued at approximately $5.15 million, to cryptocurrency exchanges Binance and OKX on May 2nd. These transfers occurred after the $BIO price had increased by 100% over two days. Reports also indicated an initial movement of 1.2 billion tokens from team-linked multi-sig wallets to three new addresses, preceding the 80 million sent to exchanges. These actions raised questions within the community regarding token distribution and liquidity management, with social sentiment for $BIO showing a 15% increase in negative mentions related to 'team dump' and 'liquidity concerns'.
Protocol Development and Future Initiatives
The $BIO Protocol continues to develop its ecosystem, including a launchpad activity in collaboration with $peptai_. The $peptai_ token sale is live and scheduled to conclude on May 14, allocating 20% of tokens to existing $BIO stakers and an additional 5% via an ignition sale. The $peptai_ project aims to identify and fund peptide drug discovery concepts, progressing from AI-driven identification to wet lab experimentation. The $BIO Protocol introduced a new staking program for $BIO tokens, designed to enable participation in these launchpad opportunities.